Moteur de recherche d’entreprises européennes
Financement de l’UE (3 971 348 €) : Outils moléculaires pour la manipulation des acides nucléiques en vue d’une intervention biologique Hor26/09/2016 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Outils moléculaires pour la manipulation des acides nucléiques en vue d’une intervention biologique
MMbio will bridge the classically separate disciplines of Chemistry and Biology by assembling leading experts from academia and non-academic partners (industry, technology transfer & science communication) to bring about systems designed to interfere therapeutically with gene expression in living cells. Expertise in nucleic acid synthesis, its molecular recognition and chemical reactivity is combined with drug delivery, cellular biology and experimental medicine. This project represents a concerted effort to make use of a basic and quantitative understanding of chemical interactions to develop and deliver oligonucleotide molecules of utility for therapy. Our chemical biology approach to this field is ambitious in its breadth and represents a unqiues opportunity to educate young scientists across sectorial and disciplinary barriers. Training will naturally encompass a wide range of skills, requiring a joint effort of chemists and biologists to introduce young researchers in a structured way to and array of research methodologies that no single research grouping could provide. The incorporation of early-stage and later stag ebiotechnology enterprises ensures that commercialisation of methodologies as well as the drug development process is covered in this ITN. We hope that MMBio will train scientists able to understand both the biological problem and the chemistry that holds the possible solution and develop original experimental approaches to stimulate European academic and commercial success in this area.
| Alzheimer's Society | ? |
| Astrazeneca AB | 263 659 € |
| JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN | 249 216 € |
| Karolinska Institutet | 263 659 € |
| Medimmune Ltd. | 273 288 € |
| Region Stockholm | 263 659 € |
| Rise Research Institutes OF Sweden AB | 234 364 € |
| SP Process Development AB | 29 295 € |
| The Chancellor Masters and Scholars of the University of Cambridge | 546 576 € |
| The University of Sheffield | 546 576 € |
| TURUN YLIOPISTO | 269 145 € |
| Universita Degli Studi Di Padova | 516 123 € |
| UNIVERSITAET BERN | 265 227 € |
| Universiteit Gent | 250 560 € |
https://cordis.europa.eu/project/id/721613
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Alzheimer's Society, Londres, Royaume Uni.